Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.9800
+0.3180
+(48.04%)
At close: February 21 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
5/31/2020
Operating Cash Flow
-317.1620
-497.4670
-690.1290
-679.2360
-986.7610
Investing Cash Flow
--
433
343
27.6370
750
Financing Cash Flow
70
--
341.6320
525.0030
--
End Cash Position
5.7360
156.1780
220.6450
226.1420
749.1680
Income Tax Paid Supplemental Data
--
2.4000
2.4000
2.4000
1.6000
Issuance of Debt
70
--
341.6320
525.0030
--
Free Cash Flow
-317.1620
-497.4670
-690.1290
-679.2360
-986.7610
5/31/2020 - 1/2/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OTLC Oncotelic Therapeutics, Inc.
0.0300
-13.04%
PMCB PharmaCyte Biotech, Inc.
1.7600
-2.76%
ENTX Entera Bio Ltd.
2.1000
-4.11%
CELZ Creative Medical Technology Holdings, Inc.
5.40
-9.85%
NWBO Northwest Biotherapeutics, Inc.
0.2500
+2.00%
CVM CEL-SCI Corporation
0.3960
-6.38%
VKTX Viking Therapeutics, Inc.
34.07
+7.71%